A	O
novel	O
role	O
of	O
thrombospondin	O
-	O
1	O
in	O
cervical	B-Multi-tissue_structure
carcinogenesis	O
:	O
inhibit	O
stroma	B-Tissue
reaction	O
by	O
inhibiting	O
activated	O
fibroblasts	B-Cell
from	O
invading	O
cancer	B-Cancer
.	O

Thrombospondin	O
(	O
TSP	O
)	O
-	O
1	O
,	O
a	O
potent	O
angiogenesis	O
inhibitor	O
,	O
has	O
been	O
shown	O
to	O
exert	O
different	O
biological	O
functions	O
on	O
various	O
cell	B-Cell
types	O
.	O

Here	O
,	O
we	O
investigate	O
the	O
role	O
of	O
TSP	O
-	O
1	O
in	O
tumor	B-Cancer
-	O
stroma	B-Tissue
reaction	O
,	O
which	O
is	O
mainly	O
characterized	O
by	O
fibroblast	B-Cell
activation	O
to	O
create	O
a	O
permissive	O
microenvironment	O
for	O
tumor	B-Cancer
progression	O
.	O

Immunohistochemistry	O
examinations	O
in	O
the	O
human	O
surgical	B-Cancer
specimens	I-Cancer
have	O
shown	O
that	O
a	O
downregulation	O
of	O
TSP	O
-	O
1	O
during	O
the	O
progression	O
of	O
cervical	B-Multi-tissue_structure
carcinogenesis	O
was	O
accompanied	O
by	O
an	O
emergence	O
in	O
the	O
upregulation	O
of	O
stroma	B-Tissue
markers	O
,	O
alpha	O
-	O
smooth	O
muscle	O
actin	O
(	O
alpha	O
-	O
SMA	O
)	O
and	O
desmin	O
.	O

Transfection	O
of	O
SiHa	B-Cell
cervical	I-Cell
cancer	I-Cell
cells	I-Cell
with	O
a	O
plasmid	B-Cellular_component
expressing	O
the	O
TSP	O
-	O
1	O
protein	O
exhibited	O
antiangiogenic	O
activity	O
in	O
vitro	O
and	O
resulted	O
in	O
reduced	O
tumor	B-Cancer
growth	O
in	O
severe	O
combined	O
immunodeficiency	O
(	O
SCID	O
)	O
mice	O
,	O
which	O
was	O
accompanied	O
by	O
a	O
decrease	O
in	O
tumor	B-Cancer
vascularization	O
and	O
lower	O
expressions	O
of	O
alpha	O
-	O
SMA	O
and	O
desmin	O
than	O
those	O
in	O
the	O
vector	O
controls	O
.	O

Transfection	O
with	O
TSP	O
-	O
1	O
and	O
purified	O
TSP	O
-	O
1	O
added	O
to	O
NIH3T3	B-Cell
cells	I-Cell
did	O
not	O
alter	O
the	O
protein	O
levels	O
of	O
alpha	O
-	O
SMA	O
and	O
desmin	O
but	O
significantly	O
inhibited	O
matrix	O
metalloprotease	O
-	O
2	O
activity	O
.	O

Transforming	O
growth	O
factor	O
-	O
beta	O
(	O
TGF	O
-	O
beta	O
)	O
,	O
a	O
major	O
factor	O
in	O
the	O
activation	O
of	O
fibroblasts	B-Cell
,	O
increased	O
alpha	O
-	O
SMA	O
and	O
desmin	O
expression	O
and	O
the	O
ability	O
of	O
cell	B-Cell
migration	O
and	O
invasion	O
in	O
NIH3T3	B-Cell
cells	I-Cell
.	O

The	O
increased	O
migration	O
ability	O
and	O
the	O
invasive	O
ability	O
into	O
tumor	B-Cancer
cluster	O
of	O
TGF	O
-	O
beta	O
-	O
treated	O
NIH3T3	B-Cell
cells	I-Cell
were	O
dose	O
dependently	O
inhibited	O
by	O
TSP	O
-	O
1	O
.	O

In	O
contrast	O
,	O
ectopic	O
TSP	O
-	O
1	O
expression	O
in	O
SiHa	B-Cell
cells	I-Cell
has	O
little	O
effect	O
on	O
the	O
invasive	O
ability	O
of	O
the	O
NIH3T3	B-Cell
cells	I-Cell
.	O

Together	O
,	O
our	O
findings	O
demonstrate	O
a	O
novel	O
role	O
of	O
TSP	O
-	O
1	O
to	O
inhibit	O
tumor	B-Cancer
-	O
stroma	B-Tissue
reaction	O
that	O
could	O
be	O
attributed	O
to	O
the	O
blockage	O
of	O
activated	O
fibroblasts	B-Cell
from	O
invading	O
cancer	B-Cell
cells	I-Cell
.	O

